SuperworthCareDx EPS CDNA
Diluted earnings per share by quarter and over the last twelve months, from 2013.
- Last 12 months, to Jun 30, 2026
- $2.07
- Latest quarter, Q2 FY26
- $2.07
- Fiscal year 2025
- −$0.40
- −148% on the year before
CareDx's earnings per share was $2.07 over the twelve months to Jun 30, 2026, up 116% on a year earlier.
In its latest quarter, Q2 FY26, it was $2.07.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.40 | −148% |
| FY2024 | $0.84 | n/a |
| FY2023 | −$3.54 | n/a |
| FY2022 | −$1.44 | n/a |
| FY2021 | −$0.59 | n/a |
| FY2020 | −$0.42 | n/a |
| FY2019 | −$0.52 | n/a |
| FY2018 | −$1.33 | n/a |
| FY2017 | −$2.21 | n/a |
| FY2016 | −$2.57 | n/a |
| FY2015 | −$1.15 | n/a |
| FY2014 | −$1.04 | n/a |
| FY2013 | −$3.50 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $2.07 | n/a | $2.07 | |
| Q1 FY26 | $0.05 | n/a | −$0.16 | |
| Q4 FY25 | −$0.08 | −105% | −$0.40 | |
| Q3 FY25 | $0.03 | n/a | $1.19 | |
| Q2 FY25 | −$0.16 | n/a | $0.96 | |
| Q1 FY25 | −$0.19 | n/a | $1.03 | |
| Q4 FY24 | $1.51 | n/a | $0.84 | |
| Q3 FY24 | −$0.20 | n/a | −$2.88 | |
| Q2 FY24 | −$0.09 | n/a | −$3.11 | |
| Q1 FY24 | −$0.38 | n/a | −$3.48 | |
| Q4 FY23 | −$2.21 | n/a | −$3.54 | |
| Q3 FY23 | −$0.43 | n/a | −$1.67 |
Against its peers
Companies in Medical - Diagnostics & Research nearest CareDx's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CDNACareDx | $2.07 | +116% a year |
| VCYTVeracyte | $1.40 | +324% a year |
| BLLNBillionToOne | $0.65 | |
| LNTHLantheus | $4.13 | +10% a year |
| CAICaris Life Sciences | $0.37 | |
| BIOBio-Rad Laboratories | $8.25 | −30% a year |
| RVTYRevvity | $2.10 | −11% a year |
| MEDPMedpace | $17.05 | +27% a year |
| NRCNRC Health | $0.25 | −67% a year |
| LHLabcorp | $12.09 | +33% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| Peer median | $3.12 |
Where CareDx ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on CareDx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.